Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. May 6, 2021; 9(13): 2994-3007
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.2994
Table 1 Patient demographics and clinical characteristics in the training and internal validation sets

Training sets
Internal testing sets
Mild, n = 224 (62.0%)
Severe, n = 38 (10.5%)
P value
Mild, n = 90 (25.8%)
Severe, n = 9 (2.5%)
P value
Age (yr)48.5 (36.0-59.0)64 (57.5-66.0)43.0 (34.0-54.8)64.0 (62.0-69.0)
≥ 60 yr54 (24.1)26 (68.4)0.00014 (15.6)8 (88.9)0.000
Sex0.0020.159
Male106 (47.3)29 (76.3)38 (42.2)6 (66.7)
Female118 (52.7)9 (23.7)52 (57.8)3 (33.3)
BMI > 2457 (25.4)11 (28.9)0.00022 (24.4)4 (44.4)0.024
BMI > 2721 (9.4)14 (36.8)5 (5.6)2 (22.2)
Onset to hospitalization (> 5 d)62 (27.7)25 (65.8)0.00034 (37.8)5 (55.6)0.000
Symptoms
Fever > 37.3°C172 (76.8)29 (76.3)0.00078 (86.7)7 (77.8)0.005
Fever > 39°C8 (3.6)7 (18.4)1 (1.1)2 (22.2)
Charlson index > 072 (32.2)33 (86.8)0.00039 (43.3)8 (88.9)0.000
P/F13 (5.8)16 (42.1)0.0003 (3.3)3 (33.3)0.006
NLR > 280 (35.7)15 (39.5)0.00039 (16.7)3 (33.3)0.009
NLR > 424 (10.7)17 (44.7)7 (7.8)4 (44.4)
Score ≥ 731 (13.8)35 (92.1)0.00013 (13.1)9 (100)0.000
Table 2 Demographic clinical characteristics of external validation sets

Mild, n = 110 (%)
Severe, n = 16
P value
Age (yr)49.0 (35.0-57.8)70.0 (64.0-78.0)
> 6027 (24.6)12 (75.0)0.000
Sex0.007
Male51 (46.4)13 (81.3)
Female59 (53.6)3 (18.7)
BMI > 2430 (27.3)8 (50.0)0.021
> 2715 (13.6)4 (25.0)
Onset to hospitalization (> 5 d)37 (33.6)15 (94.0)0.000
Symptoms
Fever > 37.3°C87 (79.1)12 (75.0)0.025
Fever > 39°C4 (3.6)3 (18.8)
Charlson index > 054 (49.1)15 (93.8)0.000
P/F1 (0.9)6 (37.5)0.000
NLR > 244 (40.0)2 (12.5)0.000
NLR > 46 (5.5)14 (87.5)
Score ≥ 723 (20.9)15 (93.8)0.000
Table 3 Risk factors of severe patients with coronavirus disease 2019
Variable
Univariate analysis
Multivariate analysis
OR
P value
OR
P value
Age ≥ 60 yr6.821 (3.224-14.431)0.000--
Sex3.587 (1.624-7.924)0.002--
BMI2.701 (1.727-4.224)0.0003.939 (1.409-11.015)0.009
Illness onset at admission5.025 (2.418-10.441)0.0007.107 (1.449-34.849)0.016
Smoker4.060 (1.912-8.621)0.000--
Dry cough3.395 (1.604-7.184)--
Productive sputum2.612 (1.284-5.312)0.008--
Fever4.615 (1.948-10.935)0.0016.794(1.401-32.951)0.017
Shortness of breath3.312 (1.161-9.448)0.025--
Fatigue3.450 (1.661-7.164)0.001--
Charlson index2.371 (1.813-3.100)0.0002.917 (1.279-6.654)0.011
PaO2/FiO211.804 (5.028-27.714)0.00017.570 (1.117-276.832)0.041
Platelet count0.423 (0.180-0.992)0.048--
NLR3.766 (2.271-6.245)0.0003.574 (1.048-12.191)0.042
D-Dimer4.385 (2.102-9.148)0.000--
ESR11.023 (2.583-47.048)0.001--
hs-CRP4.314 (2.359-7.887)0.000--
AST6.332 (2.753-14.563)0.000--
Cr16.258 (3.994-66.188)0.000--
IL-62.346 (1.224-4.494)0.010--
PCT3.961 (1.062-14.772)0.040--
ROX0.237 (0.111-0.505)0.000--
Table 4 The proposed score rules for clinical diagnosis of severe coronavirus disease 2019
VariablesDescriptionScore
BMI≥ 241
≥ 272
Time from onset to admission≥ 5 d2
Fever≥ 37.3 °C2
≥ 39 °C4
Charlson index 1
P/F score< 3006
NLR≥ 21
≥ 42
Table 5 Comparison of predictive performance between the proposed method and CURB-65

Proposed model
CURB-65
Internal validation
AUROC0.941 (0.901-0.981)0.704 (0.564-0.863)
Precision0.270 (0.234-0.307)1.000
Sensitivity0.930 (0.896-0.964)0.156 (0.085-0.228)
Specificity0.622 (0.602-0.641)1.000
External validation
AUROC0.936 (0.886-0.987)0.654 (0.518-0.791)
Precision0.413 (0.261-0.565)0.481 (0.254-0.708)
Sensitivity0.927 (0.873-0.980)0.292 (0.186-0.399)
Specificity0.804 (0.728-0.880)0.954 (0.925-0.983)